![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](gg2050contents.gif)
Acta Cryst. (2008). E64, m190 [ doi:10.1107/S1600536807065816 ]
Abstract: In the title compound, [Cu(C16H14N5)2]Cl2·2CH4O·2H2O, the cationic metal complex resides on a crystallographic centre of inversion, with the Cu2+ bonded to two bis(1H-benzimidazol-2-ylmethyl)amines (IDB). The coordination geometry of the Cu2+ ion is distorted octahedral with an N6 ligand set. A three-dimensional framework structure is formed by means of hydrogen bonds and
-
interactions formed between imidazole and phenyl rings, and between phenyl and phenyl rings, with centroid-to-centroid distances of 3.690 (2)-3.977 (2) Å and interplanar spacings of 3.445 (2)-3.502 (2) Å.
Online 18 December 2007
Copyright © International Union of Crystallography
IUCr Webmaster